Higher Guidance Puts a Digital Health Turnaround in Focus
Amwell (NYSE: AMWL) is giving many a more compelling reason to revisit its digital healthcare story: a clearer route toward operating cash generation, a higher revenue outlook and a platform strategy built around…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
Smaller Losses, Substantial Cash and a More Interesting Business
Amwell (NYSE: AMWL) heads into its third-quarter earnings announcement with a proposition worth watching: a technology-enabled healthcare business approaching adjusted operating breakeven, supported by nearly $196 million in cash and equivalents and a…
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
NYSE trading floor with screens showing stocks sliding as rising U.S. Treasury yields and Walmart (WMT) earnings pressure risk assets on August 20, 2026.
McDonald’s Corp. (NYSE: MCD), Similarweb Ltd. (NYSE: SMWB), and Amwell (NYSE: AMWL) are pursuing distinctly different strategies, but their direction points to one increasingly investable conclusion: companies that own meaningful customer interactions are finding new ways to monetize the data, workflow and…
Wall Street’s AI trade is beginning to look less like a one-company coronation and more like an expanding commercial ecosystem. Meta Platforms (NASDAQ: META), Advanced Micro Devices (NASDAQ: AMD), Apple (NASDAQ: AAPL), Amwell (NYSE: AMWL) and LG Display (NYSE: LPL) each offer…
Oura’s proposed Nasdaq debut under OURA is shaping up as more than another wearable-device listing. It is a high-growth health-intelligence story built around a deceptively simple object: a screenless ring that turns sleep, stress, activity, heart health, metabolic health, and women’s health data into…
Beta Bionics, Inc. (NASDAQ: BBNX) has priced a $150 million public offering this week just as its product story is acquiring more commercial torque: FDA clearance for the Mint™ patch pump, a planned U.S. launch in the first quarter of 2027, and a…
Artificial intelligence’s investment story is broadening from a race to build the largest models into a more commercially durable contest: who can deploy capable AI securely, govern it responsibly and connect it to real-world workflows. That shift puts NVIDIA Corp. (NASDAQ: NVDA),…
